Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Name: Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Published: 2012
License: Public Domain

Orexigen Therapeutics, Inc · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

body-weight cardiovascular-diseases diabetes-mellitus metabolic-diseases obesity overweight type-2

obesity, overweight, body weight, bupropion, cardiovascular diseases, diabetes mellitus, diabetes mellitus, type 2, endocrine system diseases, glucose metabolism disorders, heart diseases, metabolic diseases, narcotic antagonists

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 858359
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.